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HDLLiver X receptors (LXRα and LXRβ) are key transcription factors in cholesterol metabolism that regulate cholesterol
biosynthesis/efﬂux and bile acid metabolism/excretion in the liver and numerous organs. In macrophages, LXR sig-
naling modulates cholesterol handling and the inﬂammatory response, pathways involved in atherosclerosis. Since
regulatory pathways of LXR transcription control are well understood, in the present study we aimed at identifying
post-transcriptional regulators of LXR activity. MicroRNAs (miRs) are such post-transcriptional regulators of genes
that in the canonical pathwaymediatemRNA inactivation. In silico analysis identiﬁedmiR-206 as a putative regula-
tor of LXRα but not LXRβ. Indeed, as recently shown,we found thatmiR-206 represses LXRα activity and expression
of LXRα and its target genes in hepatic cells. Interestingly, miR-206 regulates LXRα differently inmacrophages. Sta-
bly overexpressingmiR-206 in THP-1 humanmacrophages revealed an up-regulation andmiR-206 knockdown led
to a down-regulation of LXRα and its target genes. In support of these results, bone marrow-derived macrophages
(BMDMs) frommiR-206KOmice also exhibited lower expression of LXRα target genes. The physiological relevance
of these ﬁndings was proven by gain- and loss-of-function of miR-206; overexpression of miR-206 enhanced cho-
lesterol efﬂux in human macrophages and knocking out miR-206 decreased cholesterol efﬂux from MPMs. More-
over, we show that miR-206 expression in macrophages is repressed by LXRα activation, while oxidized LDL and
inﬂammatory stimuli profoundly induced miR-206 expression. We therefore propose a feed-back loop between
miR-206 and LXRα that might be part of an LXR auto-regulatory mechanism to ﬁne tune LXR activity.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Whole body metabolism and the cellular homeostasis of cholesterol
are complex and governed by de novo biosynthesis, cholesterol absorp-
tion and cholesterol elimination [1]. In dyslipidemia, which predisposes
to atherosclerosis, the balance between cholesterol uptake, synthesis
and cellular export is disrupted [2,3]. Cholesterol homeostasis iss; ApoE, apolipoprotein E; ABCs,
P, sterol regulatory element-
ogy and Biochemistry, Medical
tria. Tel.: +43 316 380 4202;
. Kostner).
. This is an open access article underintricately regulated by a battery of transcription factors among which
liver X receptors (LXRs) are nuclear receptors that play a crucial role
in transcriptional regulation of lipid metabolism and inﬂammation [1].
LXRβ is ubiquitously expressed whereas LXRα is expressed in all meta-
bolically active tissues such as the liver, adipose tissue, kidney, intestine,
and in cells such as themacrophages, lung and adrenal glands. LXRs are
“cholesterol sensors” activated by elevated intracellular oxysterols and
intermediates of the cholesterol biosynthetic pathway, which in turn
transcriptionally regulate genes that are involved in reverse cholesterol
transport, cholesterol conversion to bile acids and intestinal absorption
[2].
In macrophages, LXRs regulate several genes involved in cholesterol
transport and lipid metabolism such as the ATP-binding cassette trans-
porters (ABCs) ABCA1 and ABCG1, apolipoprotein E (ApoE), lipoproteinthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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inmacrophages promotes cholesterol efﬂux and protects against devel-
opment of atherosclerosis. An E3 ubiquitin ligase (IDOL) which is a
direct LXRα target gene has been shown to reduce cholesterol accumu-
lation in cells by post-translationally degrading low-density lipoprotein
receptor (LDLR), very low-density lipoprotein receptor (VLDLR) and
ApoE receptor 2 (ApoER2) [4–6]. In addition to its role in cholesterol
homeostasis LXRα has been implicated as regulator of inﬂammation
and innate immunity. Recently, LXRα has also been reported to be
atheroprotective by othermechanisms such as in the control of iron ho-
meostasis, in which it enhances iron recycling capabilities by increasing
iron release from macrophages [7].
Though athero-protective, the major drawback of LXR agonists as
potential drugs to treat cardiovascular diseases is their stimulating
effect on hepatic lipogenesis and increase of plasma triglyceride levels
thereby promoting hepato-steatosis [8]. Hence a better understanding
of the mechanisms controlling tissue speciﬁc functions of LXR is of
immense interest [9,10].
MicroRNAs (miRs) are important post-transcriptional regulators of
gene expression that play crucial roles in numerous biological path-
ways. miRs are 20–25 nt small non-coding RNA molecules that control
gene expression through base pairing between the seed sequence of
the miR and its complementary match sequence on the target mRNA
[11]. miRs play important roles in the physiology and pathophysiology
of cell function, differentiation and growth [12,13]. There are more
than 70 human diseases that ﬁnd direct correlation to the differential
expression of a single tissue speciﬁc miR or a speciﬁc family of miRs
[12,13].
In this paper we report a novel miR-206 mediated regulation of
macrophage LXRα gene expression in both human and mouse macro-
phages. Interestingly, we observe that this regulation occurs differently
in the liver. We also observe a reciprocal feed-back repression of miR-
206 expression in response to LXRα activation in macrophages.
2. Methods
2.1. Animals
All animal experiments were carried out in accordance with the
guidelines of the Division of Genetic Engineering and Animal Experi-
ments, Austrian Federal Ministry of Science and Research (Vienna,
Austria). miR-206 knockout (KO) mice were obtained from Dr. Eric N.
Olson's laboratory (Department of Molecular Biology, University of
Texas Southwestern Medical Center, TX). WT mice and miR-206 KO
mice were on a mixed background (29SvEv–C57BL/6). All animals
were fed ad libitum with normal chow diet (caloric intake = 11.9%
from fat; Ssniff®, Soest, Germany) and were maintained in a 12 h
light/dark cycle in a temperature controlled environment.
2.2. Cell lines and cell experiments
HepG2 and COS-7 cells used in this study were obtained from
American Type Culture Collection (ATCC) and were grown in DMEM
supplemented with 10% fetal bovine serum and 1% pen–strep (penicil-
lin–streptomycin). THP-1 cells were maintained in RPMI media
(Gibco; Invitrogen, CA, USA) supplemented with 10% fetal bovine
serum and 1% pen–strep. For differentiating THP-1 cells, the cells were
treated with 100 nM phorbol 12-myristate 13-acetate (PMA; Sigma#
P 8139, St. Louis, USA) for 3 days.
Mouse bonemarrow-derivedmacrophages (BMDMs) and peritone-
al macrophages (MPMs) were prepared as described earlier [14].
Human peripheral blood mononuclear cells were isolated from normo-
lipidemic individuals and were differentiated into monocyte-derived
macrophages (MDMs) as previously described [7].
THP-1 cells were starved for 12 h and treated with LXR agonists TO-
901317 (TO9, 1–10 μM) andGW3965 (GW, 1 μM) for 24 h. Alternatively,cells were incubated for 24 h with the given amounts of acLDL, oxLDL or
VLDL. Lipoproteins were prepared as described [15,16].
2.2.1. LPS treatment and TNFα treatment
PMA-treated THP-1 cells were serum starved for 12 h and treated
with 10 ng/ml TNFα (PeproTech, NJ). Differentiated MDMs were treat-
ed with 100 ng/ml LPS for 24 h. For details see Supplementarymaterial.
2.3. Computational prediction
The microRNA that post-transcriptionally regulated LXR was identi-
ﬁed using publicly available prediction software suite, TargetScan
(http://www.targetscan.org/). The software suite, RNAhybrid (http://
bibiserv.techfak.uni-bielefeld.de/rnahybrid/)was used further to identi-
fy the microRNA that had themost favorable binding energy to the LXR
mRNA. For predictingmicroRNA promoter interaction MicroPIR predic-
tion software was used.
2.4. miR-206 overexpression or knockout
miR-206 was expressed in HepG2 cells by transfection with 100 nM
of synthetic precursor miR-206 (Ambion®, TX, USA) usingMetafectene
PRO. The transfection was carried out as per the manufacturer's
instruction.
FormiR-206 overexpression or knockout in THP-1 cells, pCDH-CMV-
MCS-EF1-copGFP cDNA cloning and expression vector (SBI# CD511B-1,
PA, USA) or miRzip lentiviral vector (SBI# MZIPpa/aa-1) was co-
transfected with packaging vectors VSVG and PCMV (Clontech, CA,
USA) into HEK293T cells using the standard calcium phosphatemethod.
Viruses were harvested by centrifuging the supernatant at 2000 g for
20 min at 4 °C. The supernatant was ﬁltered and puriﬁed further and
the viral stocks were aliquoted and maintained at −80 °C until use.
THP-1 cells were transfected using the viral particles and GFP positive
cells were sorted out using FACSCalibur (BD Biosciences, New Jersey,
USA).
2.5. Protein extraction, Western blot, RNA extraction and quantitative real
time PCR analyses
Protein extraction andWestern blot analysis were carried out as de-
scribed [17]. Details of the antibody dilutions used for Western blot are
as follows: LXRα (1:500 dilution, #ab41902, Abcam, Cambridge, UK),
ABCA1 (1:1000, #NB400-105, Novus Biologicals, Cambridge, UK),
GAPDH (1:1000, #sc-365062, Santa Cruz Biotechnology, TX, USA), and
Calnexin (1:1000, #sc-11397, Santa Cruz Biotechnology, TX, USA).
RNAextraction and quantitative real time PCR are described in detail
in the Supplementary material. In short, total RNA was extracted with
Trifast (Peqlab, Erlangen, Germany) and reverse transcribed (High
Capacity cDNA Reverse Transcription Kit, Applied Biosystems, Carlsbad,
CA). The quantity of RNA used in quantitative real time PCR was
optimized prior to obtain ct values within the range of 18–30.
For mature miR-206 quantiﬁcation the miRCURY LNA™ Universal
RT microRNA PCR system (Exiqon, Vedbaek, Denmark) was used to-
gether with miR-206 or U6 (reference gene) speciﬁc predesigned LNA
primers. Quantitative real time PCR was carried out using gene speciﬁc
primers and QuantiFast SYBR Green PCR Kit (Qiagen, Germany) on
LC480 (Roche Diagnostics, Basel, Switzerland). All samples were nor-
malized to cyclophilin A mRNA expression. Experiments were carried
out in triplicates.
2.6. Luciferase reporter assays
Details of these experiments are given in the Supplementarymateri-
al. In short, a 52 base pair putative miR-206 target sequence from the 3′
UTR region of LXR, or a scrambled negative control was cloned using
PremiR-Reporter constructs and synthetic Pre-miR206 from Ambion
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For the luciferase assay, 100 ng/ml of the PremiR-Reporter construct
was co-transfected with 25 ng/ml β-Gal control plasmid and also with
the 100 nM synthetic precursor-miR206 strand or the 1 μg/ml of miR-
206 expression vector into COS-7 cells usingX-tremeGENE siRNATrans-
fection Kit (Roche). After 36 h, cells were lysed and 50 μl of the lysate
was used for β-Gal assay and 10 μl (2×) was used for luciferase assay
carried out using the manufacturer's protocol.2.7. Cholesterol efﬂux assay
Cholesterol efﬂux assay was performed in MPMs after loading with
[3H]cholesterol labeled ac-LDL as described earlier [15]. Cholesterol ef-
ﬂux assay in THP-1 cells was performed as described in the Supplemen-
tary methods section.2.8. Statistics
All statistical analyses were performed using GraphPad Prism 5.0. In
cholesterol efﬂux assays the differences between groups were analyzed
using two-tailed, unpaired Student's t-test. All qRT-PCR experiments
were calculated using REST2009.Fig. 1. a) Conserved binding site for miR-206 on LXRαmRNA. Top: Stem loop structure of miR
putatively bind to the LXRα 3′UTR region is represented in pink and the conserved miR-206 bi
ciferase activity of the LXR 3′UTR construct and the 3′UTR scrambled construct. Mean values ±3. Results
3.1. miR-206 targets the conserved 3′UTR of LXRα in humans and several
mammals
To identify post-transcriptional regulators of LXRα, we performed in
silico analysis of LXRαmRNA sequence using the TargetScan microRNA
prediction tool. TargetScan analysis revealed miR-206 to be a putative
miR that potentially targets the 3′UTR of LXRα mRNA. Fig. 1a shows
the stem miR-206 loop structure, the mature miR-206 sequence and
the conserved binding site of miR-206 on the LXRα 3′UTR of human
and several mammals.
We further examined the feasibility of the predicted interaction
using the RNAhybrid program that predicts the minimum free binding
energy (mfe) of miR206–LXRα interaction. This analysis revealed that
the interaction between miR206–LXRα has a favorable mfe of (−)
23.5 kcal/mol. LXRβ lacked miR-206 binding sites and therefore was
not among the predicted miR-206 targets.
To determine whether the predicted miR-206 binding site on LXRα
3′UTR was functional, we cloned the 3′UTR region of LXRα (LXR 3′UTR
clone) or a scrambled seed sequence clone of the 3′UTR LXRα (scram-
bled control) into a miR-luciferase reporter construct. As shown in
Fig. 1b, luciferase activity of the LXRα 3′UTR clone was markedly re-
duced in COS7 cells transfected with a miR-206 expression plasmid
whereas the cells transfected with the scrambled control plus the-206 from which the mature miR-206 is formed. The seed sequence of miR-206 that can
nding site on LXRαmRNA is highlighted in blue. b) Luciferase reporter assay: Relative lu-
SEM from three separate experiments are as indicated;***p b 0.001.
Fig. 2. Effect ofmiR-206 knockout onmRNA and protein expression of LXRα and its target genes in the liver. a)Western blot of LXRα from the liver ofmiR-206KO andWTmice fed normal
diet (n = 6). b) mRNA abundance of LXRα and its target genes in WT and in miR 206 KO liver by qRT-PCR (n = 4). Mean values ± SEM from three separate experiments are
indicated;*p b 0.05; **p b 0.01; ***p b 0.001.
Fig. 3. Regulation of LXRα expression and its target genes bymiR-206 in THP-1 cells. After differentiation, protein andmRNA expressions of LXRα and its target genes were determined in
control THP-1, THP-1miR206 OE and THP-1miR206 KO cells. a) Western blot of basal or TO9 or GW-induced LXRα protein from control THP-1, THP-1miR206 KO and THP-1miR206 OE
cells. Western blots are from one representative experiment out of four experiments (t test: THP-1miR206 OE vs. control and TO9 or GW-induced expression of LXRα in THP-1miR206 OE
vs. control THP-1 cells; $p b 0.05; THP-1miR206 OE vs. THP-1miR206 KO and TO9 or GW-induced expression of LXRα in THP-1miR206 OE vs. THP-1miR206 KO; #p b 0.05; untreated
control vs. TO9 or GW-induced expression of LXRα in THP-1, THP-1miR2-6-KO and THP-1miR206-OE cells; *p b 0.05; ***p b 0.001). b) Basal mRNA abundance of LXRα target genes in
THP-1 cells by qRT-PCR. c) TO9-induced mRNA abundance of LXRα target genes by qRT-PCR. Mean values ± SEM from three separate experiments are indicated; *p b 0.05;
***p b 0.001.
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tivity. As indicated in Fig. 1b, the basal luciferase activities of both the
LXR 3′UTR clone and the scrambled control were comparable.
3.2. miR-206 represses mRNA expression of LXRα and its target genes in
HepG2 cells
While this studywas in progress, Zhong et al. reported that miR-206
reduces LXRα signaling in mouse primary hepatocytes and in human
HepG2 cells [18]. In order to conﬁrm and extend these observations,
we studied the expression of LXRα and its target genes in HepG2 cells
transfected with pre-miR-206. Supplementary Fig. S2.1a shows that in
miR-206 overexpressing HepG2 cells treated with the LXRα agonist
TO901317 (TO9, 10 μM), LXRα expression was reduced by 50%, and
the expression of the target genes ABCA1, ABCG1, SREBP-1c and
ABCG5was reduced by 75–85%. ABCG8 expressionwas not signiﬁcantly
affected. LXRα protein expression in TO9-activatedmiR-206 expressing
cells was also reduced by up to 50% (Supplementary Fig. S2.1b).
3.3. The expression of LXRα and its target genes is increased in miR206 KO
liver
In order to substantiate the physiological relevance of theseﬁndings,
LXRα mediated pathways were investigated in miR-206 KO mice. In
Fig. 2a we show, that LXRα protein expression in miR-206 KO liver is
markedly increased by up to 75%. In addition, we noticed a signiﬁcantFig. 4. Effect of miR-206 knockout onmRNA LXRα target genes in untreated and LXRα ligand tr
by qRT-PCR. b) TO9-inducedmRNA abundance of LXRα and its target genes in miR206 KO and
miR206 KO andWT MPMs by qRT-PCR. Mean values ± SEM from three separate experiments1.5–5 fold increase in the LXRα target gene mRNA expression (ABCA1,
ABCG1, ApoE and SREBP-1c) in the liver of miR206 KO mice (Fig. 2b).
In summary, we show that miR-206 directly interacts with the 3′
UTR region of LXRα and represses its translation in HepG2 cells and in
mouse liver and thereby interferes with LXRα mediated signaling
pathways.3.4. miR-206 regulates LXRα expression differently in the liver and in
human macrophages
As LXRα plays a crucial role in regulating cholesterol efﬂux and ho-
meostasis in macrophages [9], we were further interested to study the
effect of miR-206 in macrophage cholesterol homeostasis. For this pur-
pose, we stably overexpressed (THP-1miR206 OE) or knocked down
(THP-1miR206 KO) miR-206 in the human macrophage cell line THP-
1 using lentiviral transduction. The relative expressions of miR-206
and of ABCA-1 in these cells are shown in Supplementary Fig. S2.2. Sur-
prisingly, Western blot analysis from THP-1miR206 OE cells revealed
that LXRα protein expression was markedly induced in untreated as
well as in LXR agonist-treated cells compared to control THP-1 cells. In
contrast, though not signiﬁcant both basal as well as the TO9 or
GW-induced LXRα protein expressions were moderately reduced in
THP-1miR206 KO when compared to control THP-1 cells (Fig. 3a). In
THP-1miR206 KO, TO9 or GW-induced LXRα protein expression is re-
markably lower when compared to LXRα protein expression in THP-
1miR206 OE cells.eatedMPMs. a) Basal mRNA abundance of LXRα target genes inmiR206 KO andWTMPMs
WTMPMs by qRT-PCR. c) GW-induced mRNA abundance of LXRα and its target genes in
are indicated; *p b 0.05; **p b 0.01; ***p b 0.001.
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vealed that basal mRNA levels of ABCA1, ABCG1, ApoE and SREBP-1c
were increased by 3–18 fold in THP-1miR206OE cells (Fig. 3b), whereas
LXRα target genes were less expressed in miR-206 KO THP-1 cells
(Fig. 3b), compared to control THP-1 cells. Comparable upregulation
in THP-1miR206 OE cells and downregulation in THP-1miR206 KO
cells were observed after treatment with TO9 or GW (Fig. 3c and
Supplementary Fig. S2.3).
3.5. LXRα target gene expression is reduced in miR-206 KO murine
macrophages
To examine whether this miR206–LXRα regulatory pathway is also
operative in murine systems, we studied MPMs and BMDMs obtained
from miR-206 KO and WT mice. Gene expression proﬁling of miR206
KO MPMs revealed that under basal conditions, the expression
of LXRα target genes ABCA1, ABCG1, ApoE and SREBP-1c was about
40–80% lower compared to WT MPMs (Fig. 4a). Comparable results
were also observed after treatment of MPMs with GW (Fig. 4b), yet
SREBP-1c expressionwas affected to amuch greater extent as compared
to untreatedWTMPMs (90% vs. 55%, Fig. 4a and b). TO9 treatment had
lower effect on LXRα target gene expression as compared to GW treat-
ment (Fig. 4b, c).
Similar experiments were performed in BMDMs (Fig. 5). Here,
ABCA1 expression was not signiﬁcantly different between WT BMDMs
andmiR206 KO BMDMs neither under basal conditions nor in the pres-
ence of the LXRα ligands TO9 or GW. ABCG1 and SREBP-1c expressions
were lower in miR206 KO BMDMs under basal conditions and also after
TO9 treatment and GW treatment, and ApoE expression was lower
under basal conditions and after TO9 treatment (Fig. 5a–c). Notably,
the expression of ABCG1, ApoE and SREBP-1c was affected in miR-206
KO MPMs to a greater extent than in miR206 KO BMDMs.Fig. 5. Effect of miR-206 knockout onmRNA LXRα target genes in untreated and LXRα treated B
qRT-PCR. b) TO9-induced mRNA abundance of LXRα and its target genes in miR206 KO and W
miR206 KO andWT BMDMs by qRT-PCR. Mean values ± SEM from three separate experimen3.6. miR-206 overexpression in THP-1 cells increases cholesterol efﬂux to
HDL and human serum
To investigate whether the increase in LXRα and its target genes has
functional relevance on humanmacrophages,we performed cholesterol
efﬂux assays in THP-1miR206 OE, THP-1miR206 KO and control THP-1
cells. Brieﬂy, cells were incubated with [3H]cholesterol for 24 h, and
the efﬂux to ApoA-I, HDL (ApoB depleted serum) and human serum
was measured after stimulation with TO9. Fig. 6a demonstrates that
all three cell lines efﬂuxed cholesterol efﬁciently to ApoA-I, human
serum andHDL.However, THP-1miR206 overexpression showed signif-
icantly enhanced cholesterol efﬂux capacity to human serum when
compared to control THP-1 and THP-1miR206 KO cells. Though not
signiﬁcant, THP-1miR206 OE showed an increasing tendency to efﬂux
cholesterol to HDL when compared to control THP-1 cells. In contrast
to THP-1miR206 OE, THP-1miR206 KO showed a signiﬁcantly lower
cholesterol efﬂux to HDL when compared to control THP-1miR206 OE
cells. Cholesterol efﬂux to ApoA-I and to BSA (control) was not signiﬁ-
cantly affected by miR-206 overexpression or knockout under these
experimental conditions (Fig. 6a).
Collectively, these data indicate that the miR206–LXRα pathway is
functional and of potential physiological relevance in facilitating choles-
terol efﬂux from human macrophages.
3.7. miR206 KO mouse macrophages display reduced cholesterol efﬂux to
HDL and ApoA-I
In order to substantiate these ﬁndings and to examine the physio-
logical relevance of the miR206–LXRα pathway in the murine system,
cholesterol efﬂux was also investigated in MPMs from miR206 KO and
WT mice. Fig. 6b shows that the efﬂux of cholesterol to BSA, ApoA-I,
HDL and human serum in the presence of TO9 was all signiﬁcantlyMDMs. a) Basal mRNA abundance of LXRα target genes inmiR206 KO andWT BMDMs by
T BMDMs by qRT-PCR. c) GW-induced mRNA abundance of LXRα and its target genes in
ts are indicated; *p b 0.05; **p b 0.01; ***p b 0.001.
Fig. 6. Cholesterol efﬂux assay in THP-1, THP-1miR206 OE and THP-1miR206 KO cells.
Control THP-1 cells, THP-1miR206 OE and THP-1miR206 KOwere loadedwith [3H]choles-
terol for 24 h and cholesterol efﬂux to human serum, ApoB depleted serum (HDL), and
ApoA-I was determined. a) Percentage of cholesterol efﬂux to ApoA-I, HDL and human
serumwas calculated relative to the unspeciﬁc cholesterol efﬂux to BSA. Statistical signif-
icance is indicated (t test: THP-1miR206 OE vs. control and THP-1miR206 OE vs. THP-
1miR206 KO efﬂux to human serum; #p b 0.05; THP-1miR206 OE vs. THP-1miR206 KO
efﬂux to HDL; $p b 0.05; efﬂux to ApoA-I, HDL and human serum compared to control-
BSA; *p b 0.05; **p b 0.01; ***p b 0.001). b) Cholesterol efﬂux assay from WT
and miR206KO MPMs to ApoA-I, HDL and whole human serum: MPMs were isolated
and loadedwith 3H-acLDL for 24 h and the cholesterol efﬂux assaywas performed. Results
are mean ± SEM of triplicate experiments. Statistical signiﬁcance is indicated (t test;
*p b 0.05; ***p b 0.001).
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physiological signiﬁcance of miR-206 on LXRα target genes.
3.8. LXR activation represses miR-206 expression in THP-1 macrophages
whereas ox-LDL, VLDL and other inﬂammatory stimuli induce miR-206
expression
To determine whether a feedback mechanism between LXRα and
miR-206 may exist, we activated LXR in THP-1 cells with TO9
(100 nM, 500 nM and 1 μM) and measured the expression levels of
miR-206. Notably, LXR activation by TO9 drastically repressed miR-
206 expression (Fig. 7a). We were also interested in identifying factors
that may mediate miR-206 expression in macrophages. Thus, THP-1
cells were incubated in the presence of native LDL, oxLDL or VLDL. 50–
100 μg/ml of oxLDL treatment or 50 μg/ml of VLDL treatment increased
the expression of miR-206 in THP-1 cells by 1.5–2 fold compared to
THP-1 cells incubated with native LDL (Fig. 7b).
As oxLDL robustly induced the expression of miR-206, we were
further interested to knowwhether oxLDL-induced inﬂammatory cyto-
kines such as TNFα or inﬂammatory mediators such as LPS might inﬂu-
ence the expression of miR-206. As shown in Fig. 7c a strong induction
of miR-206 expression (20-fold) in THP-1 cells was treated with10 ng/ml of TNFα. Consistently, LPS treatment of primary human
monocyte-derived macrophages also resulted in a signiﬁcantly in-
creased expression of miR-206 (Fig. 7d).
4. Discussion
The major ﬁndings of this report are: 1) miR-206 targets LXRα and
affects signaling pathways differently in the liver and macrophages of
both mouse and human, 2) the identiﬁcation of novel feedback regula-
tion between LXR andmiR206,miR-206 activates LXRαmediated path-
way in cholesterol efﬂux and LXRα autoregulates its own expression by
repressingmiR-206 and 3) and the expression of miR-206 is induced by
patho-physiological stimuli such as VLDL, oxLDL, LPS and TNFα.
miRs play important roles in a diverse spectrum of events in devel-
opment, cell growth and differentiation as well as in metabolism. The
varying expression patterns and the tissue speciﬁc functionality further
emphasize the systemic importance of microRNAs in health and dis-
eases [13]. There is an increasing body of evidence illustrating the role
of miRs in cholesterol homeostasis and atherosclerosis: Sun et al. [19]
recently published that miR-26 directly targets ABCA1 and ARL-7 RNA
and controls LXR-dependent cholesterol efﬂux from RAW264.7 cells.
Ramirez et al. [20] found a similar effect of miR-758 on ABCA1 expres-
sion and concomitantly reduced cholesterol efﬂux from human and
mouse macrophages. Rayner et al. [21,22] and Horie et al. [23] reported
thatmiR-33, that is co-transcribedwith the SREBP-2 gene targets sever-
al LXR regulated genes and that miR-33 overexpression ameliorates
cholesterol efﬂux frommacrophages. AntagonizingmiR-33 inmice pro-
moted reverse cholesterol transport and regression of atherosclerosis
[21]. Recently two independent groups published an LXRα and
farnesoid X receptor (FXR) induced expression ofmiR-144 that targeted
ABCA1 mRNA and reduced ABCA1mediated cholesterol homeostasis in
the liver [24,25]. Importantly, miR-1/206 and miR-613 have been iden-
tiﬁed as negative regulators of LXRα expression and lipogenesis in the
liver [18,26]. Notably, most of these metabolic miRs that have been
identiﬁed are reported to repress their target genes.
In thepresent studywe identiﬁed a cell-speciﬁc activity formiR-206,
which not only acts as a repressor of LXRα signaling in the liver cells but
also intriguingly acts as an activator of LXRα in macrophages. This dif-
ferential change in function is operative in both human andmousemac-
rophage systems and affects cholesterol homeostasis.
In line with earlier reports, we also observe a decrease in LXRα ex-
pression in HepG2 cells transfected with miR-206 and a concomitant
down-regulated expression of LXRα target genes, such as ABCA1,
ABCG1ABCG5 and SREBP-1c. In contrast, THP-1miR206OE cells showed
induction of LXRα and its target genes such as ABCA1, ABCG1, ApoE and
SREBP-1c accompanied with an increased cholesterol efﬂux capacity.
Exactly opposite effects were achieved with lenti-virus mediated
knockdown of miR-206 in THP-1 cells, as well as in miR206KO
BMDMs and miR-206KOMPMs, which further substantiates the activa-
tion of LXRα pathway by miR-206 in macrophages. Interestingly, the
basal unspeciﬁc cholesterol efﬂux to BSA was also reduced in miR-
206KO MPMs. Though puriﬁed albumin added to cell culture is a rela-
tively poor promoter of efﬂux, numerous studies report that aqueous
diffusion contributes signiﬁcantly to the total cell cholesterol ﬂux [27].
Therefore, the reduction in efﬂux to BSA that we observe in miR-
206KO MPMs might have been contributed by the aqueous transfer
mediated by albumin.
As miRs were traditionally described as negative regulators of gene
expression our results are quite surprising. Many recent reports suggest
that miRs can not only repress but also activate translation by multiple
mechanisms. Vasudevan [28] recently reported that during cell cycle,
miRs oscillate between activation and repression; in proliferating cells
miRs repress the translation whereas in G1/G0 arrest miRs facilitate
translational activation. One reported mechanism for activation is the
preferential interaction of AGO2–FXR1 complex (part of the miR ribo-
nucleoprotein complex) with the AU rich regions on the target mRNA
Fig. 7. Inﬂuence of LXR activation, modiﬁed lipoproteins, TNFα and LPS on miR-206 expression in THP-1 cells and human MDMs. THP-1 cells were differentiated and treated with a) 100
nM, 500 nM or 1 μMof TO9; b) 50 μg/ml of native LDL (control), 50 μg/ml VLDL or 50 or 100 μg/ml oxLDL. c) Incubation with 10 μg/ml of TNFα. d) Incubation with 100 ng/ml of LPS. The
relative abundance of miR-206 was measured by qRT-PCR. Values are mean ± SEM of three separate experiments; *p b 0.05; **p b 0.01; ***p b 0.001.
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conditions let-7 interaction with the 3′UTR region of HMGA2 leads to
activation; this mechanism also needed the interaction of AGO2–FXR1
complex with the HMGA2 mRNA [30]. A recent report from the same
group suggests that nuclear localization of AGO2–FXR1 complex along
with the target mRNA andmiR is a requirement for translational activa-
tion of the mRNA [31].
Interestingly, mature miR-206 has been reported to have both nu-
clear localization and cytosolic localization but the functional relevance
of compartmentalized localization is unknown. miR-206 is also one out
of the few miRs that were reported to have translational activation
capabilities [32,33]. Lin et al. [34] reported a feedback regulatory loop
between KLF4 and miR-206 and the context speciﬁc activation of KLF4
by miR-206 in terminally differentiated cells. In our experimental
conditions, THP-1 monocytes were differentiated into macrophages
with 100 nM PMA for three days. PMA treatment initially induces cell
cycle arrest and then terminal differentiation in macrophages. Thus
after three days of differentiation, THP-1 macrophages are terminally
differentiated cells which are thought to be incapable of further pro-
liferation. As suggested earlier, it is conceivable that FXR1–AGO2–
miR-206 complex trans-activates LXRα in THP-1miR206-OE cells by
interacting with the 3’′UTR of LXR.Similarly, miR-206-KO BMDMs were differentiated for 10 days
which also yields terminally differentiated macrophages. miR-206 KO
MPMs are already differentiatedmacrophageswhich are activated in re-
sponse to the injected thioglycollate stimuli. In miR-206-KO macro-
phages the modest reduction of LXRα expression and less pronounced
induction of TO9 or GW mediated LXRα signaling further emphasize
the native requirement of miR-206 in activating LXRα signaling. Inter-
estingly, in Fig. 3b and c, we observe a negative correlation in ABCG1
expression in THP-1miR206 OE and THP-1miR206 KO. Consistently,
we also observed a reduction in ABCG1 expression in miR-206 KO
BMDMs and MPMs (Figs. 4 & 5). This may explain the pronounced dif-
ferences in cholesterol efﬂux to HDL and complete serum in comparison
to ApoA-I. It is intriguing to speculate that the observed up- and down-
regulation of ABCG1 by miR-206 overexpression or knockdown might
be at least in part independent of LXRα, i.e. the consequence of the
direct regulation of ABCG1 expression by miR-206. However, further
work is needed to experimentally address this possibility.
miRs have also been reported to activate gene expression transcrip-
tionally by binding to the promoter sequence of the target gene [35]. To
examine the possibility of such an interaction we performed an in silico
RNAhybrid analysis which also showed a favorableminimum free bind-
ing energy (mfe) of (−) 20.3 kcal/mol. MicroPIR (microRNA-promoter
835M. Vinod et al. / Biochimica et Biophysica Acta 1841 (2014) 827–835interaction resource) is a recently developed online resource to predict
putative miR-promoter interactions. In fact, miR-206 is one among the
predicted ones which can bind at position−4809th on the ABCG1 pro-
moter with a mfe of (−) 25.50. MicroPIR also predicted miR-206 inter-
action with ApoE (at−3937) and ABCA1 (at−907). The fact that miR-
206 has been shown to localize also in the nucleus and can interact with
the promoters of the abovementioned genes suggests that such amech-
anism might also be operative in macrophages.
Lipoproteins have been recently shown to carrymiRs either through
ABCA1 mediated miR loading to HDL or through binding to circulatory
miRs [36]. miRs carried by HDL get activated inside the cell and can
regulate gene expression. Interestingly, miR-206 is also carried in the
circulation by HDL [36]. Physiologically, HDL molecules carrying miR-
206 can deliver it to macrophages by SRB-1 mediated pathway and
once inside the cells miR-206 can activate LXRα/ABCG1 mediated sig-
naling which can in turn initiate cholesterol efﬂux to HDL [36]. This
miR206–LXRα activation in macrophages might be part of the complex
cholesterol homeostasis machinery. Another important ﬁnding is the
negative feedback regulation of miR-206 by LXRα, which might be
part of the LXR auto-regulatory mechanism to ﬁne tune its own tran-
scription and expression.
Our ﬁndings that VLDL and oxLDL aswell as inﬂammatory cytokines
and mediators such as TNFα and LPS induce the expression of miR-206
highlight the importance of this miR in diseases such as atherosclerosis
and metabolic syndrome.
To summarize, we report a previously unknown pathway of miR-
206 mediated LXRα function in macrophages that inﬂuence macro-
phage cholesterol homeostasis. As LXRα is involved in various mecha-
nisms of macrophage biology and functionality, it will be important to
investigate in detail the inﬂuence of themiR-206mediated LXRα signal-
ing in a patho-physiological context such as atherosclerosis.
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